Live feed
Filing
SC 13G/A
SC 13G/A0000902664-17-003881·Mirati Therapeutics, Inc.
Schedule 13G ownership disclosure
Mirati Therapeutics Inc
Security class unavailable · CUSIP: 60468T105
Event date: 2017-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,748,101
- Percent of class
- 14.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-17-003881
- Form type
- SC 13G/A
- Filer
- Mirati Therapeutics, Inc.
- CIK
- CIK 1576263
- Filed
- Oct 03, 2017
- Reporting period
- Sep 30, 2017
- Description
- Schedule 13G beneficial ownership